Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?

Curr Opin Immunol. 1994 Aug;6(4):605-15. Unique Identifier : AIDSLINE MED/95032864
Finkel TH; Banda NK; Department of Pediatrics, National Jewish Center for Immunology; and Respiratory Medicine, Denver, Colorado 80206.


Abstract: Although twelve years have passed since the identification of HIV as the cause of AIDS, we do not yet know how HIV kills its target, the CD4+ T cell, nor how this killing cripples the immune system. Prominent theories include direct killing of infected CD4+ T cells by the action or accumulation of cytopathic viral DNA, transcripts or proteins, or by virus-specific cytotoxic T lymphocytes, and indirect killing of uninfected CD4+ T cells (and other immune cells) by autoimmune mechanisms, cytokines, superantigens, or apoptosis. In the past year, studies have provided tantalizing clues as to why infected cells may not die and how these infected cells kill innocent bystander cells.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Apoptosis/IMMUNOLOGY Cytotoxicity, Immunologic CD4-Positive T-Lymphocytes/*IMMUNOLOGY Human HIV Infections/*IMMUNOLOGY/VIROLOGY HIV-1/*PHYSIOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW, ACADEMICKWDacquiredimmunodeficiencysyndrome/immunologyapoptosis/immunologycytotoxicity,immunologiccd4-positivet-lymphocytes/KWDimmunologyhumanhivinfections/KWDimmunology/virologyhiv-1/KWDphysiologysupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticlereviewreview,academic
950228
M9521022

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .